-
Mashup Score: 0
Four patients were in Imugene’s 10-microgram dose cohort, and one patient achieved a complete response, meaning all signs of cancer…
Source: Proactiveinvestors UKCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Allergy Therapeutics hails encouraging secondary endpoint results from peanut allergy vaccine study - 3 year(s) ago
“These results provide strong confidence in the beneficial immunologic mode of action of VLP Peanut”
Source: Proactiveinvestors UKCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1
The gene silencing specialist said the latest payment related to development work on the SLN500 C3 targeting programme
Source: Proactiveinvestors UKCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Evgen Pharma now has the financial runway to exploit its technology after 'transformative' City fundraiser - 3 year(s) ago
SFX-01, the company’s lead compound. has potential applications in cancers, inflammation and acute respiratory distress syndrome
Source: Proactiveinvestors UKCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0e-Therapeutics unveils results of testing of compounds for potential coronavirus treatment - 3 year(s) ago
The company said testing from its network-driven drug discovery platform has revealed that inhibition of the same target, GRP94, is effective at…
Source: Proactiveinvestors UKCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
According to some in the industry, leaving the regulatory framework of the EU could place the British cannabis market in a position to move ahead of…
Source: Proactiveinvestors UKCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
The company is aiming to raise the cash through a combination of a placing, a subscription and a retail offer to investors
Source: Proactiveinvestors UKCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1
A look at some of the major risers and fallers in London on Wednesday
Source: Proactiveinvestors UKCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 6
The group also updated on its drug pipeline and said it was beefing up its commercial team
Source: Proactiveinvestors UKCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1e-Therapeutics PLC using its drug discovery platform in search for COVID-19 antivirals - 4 year(s) ago
e-therapeutics PLC’s (LON:ETX) CTO Jonny Wray talks Proactive London’s Andrew Scott through their drug discovery platform, the work they’ve done to date and what they’re doing currently to help find effective antivirals against coronavirus.
Source: Proactiveinvestors UKCategories: CardiologistsTweet
Imugene showcases new PD1-Vaxx data at World Conference on Lung Cancer https://t.co/Sd3PNJtMvG via @proactive_uk